tiprankstipranks
Trending News
More News >

BioVaxys Secures Key Supply to Boost Vaccine Production

Story Highlights
BioVaxys Secures Key Supply to Boost Vaccine Production

BioVaxys Technology (TSE:BIOV) has released an update.

Confident Investing Starts Here:

BioVaxys Technology Corp has secured a 48-kilogram supply of GMP-grade lipids to advance the production of its DPX-based vaccines, anticipating a significant ramp-up in preclinical and clinical programs. This acquisition is expected to save the company over a year in manufacturing lead time. BioVaxys continues to innovate with its patented DPX platform, aiming to deliver robust immune responses for various medical applications.

For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App